MSV
NKTR icon

MN Services Vermogensbeheer’s Nektar Therapeutics NKTR Stock Holding History

MN Services Vermogensbeheer’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,953
Closed -$1.04M – 529
2019
Q2 		$1.04M Hold
1,953
– – 0.01% 618
2019
Q1 		$984K Hold
1,953
– – 0.01% 597
2018
Q4 		$842K Buy
1,953
+120
+7% +$72.4K 0.01% 587
2018
Q3 		$1.68M Buy
1,833
+140
+8% +$119K 0.04% 482
2018
Q2 		$1.24M Buy
+1,693
New +$1.95M 0.03% 565

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MN Services Vermogensbeheer's NKTR Position: Q3 2019 in Review

MN Services Vermogensbeheer sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 1,953 shares — an estimated $1.04M sold.

MN Services Vermogensbeheer first reported a position in NKTR in Q2 2018 and held it in 5 quarters. The position peaked at $1.68M in Q3 2018. 288 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • MN Services Vermogensbeheer reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 1,953 Nektar Therapeutics shares in Q3 2019, an estimated $1.04M.
  • MN Services Vermogensbeheer first reported a position in Nektar Therapeutics in Q2 2018 and held it in 5 quarters.
  • MN Services Vermogensbeheer's Nektar Therapeutics position peaked at $1.68M in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on MN Services Vermogensbeheer's 13F filing for Q3 2019, filed 12 Nov 2019.